Skip to main content
This website is intended exclusively for healthcare professionals residing and/or working in Egypt.
SCIENCE
SCIENCE
SCIENCE
Cardiovascular
Cardiovascular
Cardiovascular
Thrombosis
Thrombosis
Thrombosis
Caprini risk assessment model
Padua risk assessment model
Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
Surgery for benign disease: Case presentation Prof. Juan Arcelus
VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
Hypertension
Hypertension
Hypertension
ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
Dyslipidemia
Dyslipidemia
Dyslipidemia
ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Polyvascular Disease Subanalysis
PACMAN AMI
PACMAN AMI: KOL Interview
Atherothrombosis
Atherothrombosis
Atherothrombosis
Insights and impacts from the HOST-EXAM trial
Insights and impacts from the TALOS-AMI trial
Diabetes
Diabetes
Diabetes
Diabetes Your Type
Risk Stratification of Individuals with Diabetes before Ramadan
Management of Diabetes during Ramadan
Diabetes Overview, Complications and Guidelines
The BRIGHT Study
Sanofi's Insulin Legacy & Heritage
Sanofi's Insulin Legacy & Heritage
Sanofi's Insulin Legacy & Heritage
A legacy and heritage in insulin
Our Insulin Campus
Time in Range
Time in Range
Time in Range
Time In Range Infographics
Time in Range Study
The value of time-in-range as a glycemic biomarker
Rare Diseases
Rare Diseases
Rare Diseases
Management of Gaucher Disease
Clinically multidisceplinary management
An Overview over LSDs
Insights on Gaucher disease - Genetic prespective
Delayed Diagnosis of MPS1
Overview of MPS1
Diagnosing Gaucher Disease
Overview of Gaucher Disease & Clinical picture
Gaucher : Molecular Based Definitions
MPS1 : Pathogentics
Vaccines
Vaccines
Vaccines
Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
Asthma
Asthma
Asthma
What’s the best way to talk about my Asthma?
I need a good asthma plan, but where do I start?
Optimal Asthma Control goes beyond Exacerbation Reduction
Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
PATIENT SUPPORT
PATIENT SUPPORT
Cardiovascular
Cardiovascular
Cardiovascular
How to self-inject Clexane video
Diabetes
Diabetes
Diabetes
Toujeo Patient Support Program
Soliqua Patient Support Program
How to take Toujeo
Atopic Dermatitis
Atopic Dermatitis
Atopic Dermatitis
Dupixent My Way Program
Atopic Dermatitis Patient Educational Flyer
Nasal Polys
Nasal Polys
Nasal Polys
Dupixent My Way Program
Asthma
Asthma
Asthma
Dupixent My Way Program
Bronchial Asthma Patient Educational Flyer
Dupixent How to Use Patient Booklet
Dupixent FAQ Patient Booklet
PRODUCTS
PRODUCTS
PRODUCTS
Clexane
®
Clexane®
Clexane
®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
One day surgery & fast track surgery thromboprophylaxis Guidelines
Soliqua
®
Soliqua®
Soliqua
®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Soliqua Useful Links
Depakine
®
Dapaglif
®
Dapaglif®
Dapaglif
®
Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
Dupixent
®
Dupixent®
Dupixent
®
Atopic Dermatitis
Dupixent Asthma
Dupixent Asthma
Dupixent Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Comorbidities
Type 2 Asthma With Mixed Biomarkers
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Menactra
®
Hexaxim
®
VaxigripTetra
®
Toujeo
®
Toujeo®
Toujeo
®
Time in Range Results
Praluent
®
Praluent®
Praluent
®
Know about praluent
Plavix
Plavix
Plavix
The Cure Study
PCI Cure Study
EVENTS
Log-in
Register
Search
Log-in
Register
Search
SCIENCE
SCIENCE
SCIENCE
Cardiovascular
Cardiovascular
Cardiovascular
Thrombosis
Thrombosis
Thrombosis
Caprini risk assessment model
Padua risk assessment model
Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
Surgery for benign disease: Case presentation Prof. Juan Arcelus
VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
Hypertension
Hypertension
Hypertension
ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
Dyslipidemia
Dyslipidemia
Dyslipidemia
ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Polyvascular Disease Subanalysis
PACMAN AMI
PACMAN AMI: KOL Interview
Atherothrombosis
Atherothrombosis
Atherothrombosis
Insights and impacts from the HOST-EXAM trial
Insights and impacts from the TALOS-AMI trial
Diabetes
Diabetes
Diabetes
Diabetes Your Type
Risk Stratification of Individuals with Diabetes before Ramadan
Management of Diabetes during Ramadan
Diabetes Overview, Complications and Guidelines
The BRIGHT Study
Sanofi's Insulin Legacy & Heritage
Sanofi's Insulin Legacy & Heritage
Sanofi's Insulin Legacy & Heritage
A legacy and heritage in insulin
Our Insulin Campus
Time in Range
Time in Range
Time in Range
Time In Range Infographics
Time in Range Study
The value of time-in-range as a glycemic biomarker
Rare Diseases
Rare Diseases
Rare Diseases
Management of Gaucher Disease
Clinically multidisceplinary management
An Overview over LSDs
Insights on Gaucher disease - Genetic prespective
Delayed Diagnosis of MPS1
Overview of MPS1
Diagnosing Gaucher Disease
Overview of Gaucher Disease & Clinical picture
Gaucher : Molecular Based Definitions
MPS1 : Pathogentics
Vaccines
Vaccines
Vaccines
Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
Asthma
Asthma
Asthma
What’s the best way to talk about my Asthma?
I need a good asthma plan, but where do I start?
Optimal Asthma Control goes beyond Exacerbation Reduction
Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
PATIENT SUPPORT
PATIENT SUPPORT
Cardiovascular
Cardiovascular
Cardiovascular
How to self-inject Clexane video
Diabetes
Diabetes
Diabetes
Toujeo Patient Support Program
Soliqua Patient Support Program
How to take Toujeo
Atopic Dermatitis
Atopic Dermatitis
Atopic Dermatitis
Dupixent My Way Program
Atopic Dermatitis Patient Educational Flyer
Nasal Polys
Nasal Polys
Nasal Polys
Dupixent My Way Program
Asthma
Asthma
Asthma
Dupixent My Way Program
Bronchial Asthma Patient Educational Flyer
Dupixent How to Use Patient Booklet
Dupixent FAQ Patient Booklet
PRODUCTS
PRODUCTS
PRODUCTS
Clexane
®
Clexane®
Clexane
®
Extended VTE prophylaxis in onco-surgical patients
Duration of treatment for VTE prophylaxis
Critical thrombotic period
One day surgery & fast track surgery thromboprophylaxis Guidelines
Soliqua
®
Soliqua®
Soliqua
®
OAD Uncontrolled Patients
Basal Insulin Uncontrolled Patients
Premix Uncontrolled Patients
Soliqua 2 Pens Modeling and Dosing
Soliqua Useful Links
Depakine
®
Dapaglif
®
Dapaglif®
Dapaglif
®
Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
Dupixent
®
Dupixent®
Dupixent
®
Atopic Dermatitis
Dupixent Asthma
Dupixent Asthma
Dupixent Asthma
Type 2 Asthma With Ocs Use
Type 2 Asthma With Comorbidities
Type 2 Asthma With Mixed Biomarkers
Type 2 Asthma With High Eos
Type 2 Asthma With High Ige
Menactra
®
Hexaxim
®
VaxigripTetra
®
Toujeo
®
Toujeo®
Toujeo
®
Time in Range Results
Praluent
®
Praluent®
Praluent
®
Know about praluent
Plavix
Plavix
Plavix
The Cure Study
PCI Cure Study
EVENTS
Log-in
Register
Search
Home
Science
Cardiovascular
Hypertension
Hypertension
Science in Hypertension
ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
SEE EVERYTHING
